Skip to main content

University of Miami to Study BRCA Rates in Caribbean Women

NEW YORK (GenomeWeb News) – A University of Miami researcher has reeled in a $600,000 grant from the Susan G. Komen for the Cure Foundation to study the genetic characteristics of breast cancer in women in the Caribbean.

The research will study the genetic characteristics of 1,000 breast cancer patients from four Caribbean countries by searching for the BRCA1 and BRCA2 genes, which are found in 23 percent of women with breast cancer in the Bahamas — the highest rate in the world — compared with three to five percent in the US.

"In order to further investigate this we will offer free genetic testing and counseling to women of Trinidad and Tobago, Barbados, the Cayman Islands and Dominica who have breast or ovarian cancer," principal investigator Judith Hurley, an associate professor of clinical medicine and medical director of the Hematology/Oncology Clinics at Jackson Memorial Hospital, told GenomeWeb Daily News in an e-mail.

"This research may lead to a better understanding of issues unique to black women throughout the Caribbean and in the US, as we attempt to address breast cancer's impacts across diverse groups," Komen President Elizabeth Thompson said in a statement.

This research is a collaboration with Women's College Hospital in Toronto, Hurley said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.